Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study
- PMID: 9704739
- DOI: 10.1200/JCO.1998.16.8.2854
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study
Abstract
Purpose: In childhood B-precursor acute lymphoblastic leukemia (ALL), possible interactions among sex, time, and widely used prognostic factors (age, WBC count, and DNA index) were investigated for the first 5 years after diagnosis.
Patients and methods: All eligible patients aged 1 to less than 22 years, registered between February 1986 and September 1994 in two B-precursor ALL studies from the Pediatric Oncology Group (POG), were included in the analysis. Cutpoints for age (3.0, 5.0, and 10.0 years), WBC count (10, 50, and 100 x 10(9)/L), and DNA index (DI; 1.16) were defined. Four time periods after diagnosis (years 1, 2, 3, and 4 and 5 combined) were selected for the study of prognostic significance over time. The cut-off date for analysis was April 1996.
Results: A total of 3,717 children (2,010 boys and 1,707 girls) were included in the outcome analysis. No major differences between the sexes were observed in age, duration of symptoms before registration, WBC count, hemoglobin level, platelet count, ploidy, presence of CNS disease at diagnosis, or induction failure rate. Event-free survival (EFS) differences between sexes became significantly different from 2 years following diagnosis. At 5 years, in all subsets analyzed, boys fared worse than girls, although not all differences were statistically significant. Major sex differences in EFS were observed in older children (10 to 22 years), in patients with intermediate WBC counts (10 to 50 x 10(9)/ L), and in children who fit both of these subgroups, in whom the 2-year EFS was almost 20% higher in girls than in boys, reaching a 38% difference at 5 years.
Conclusion: This study shows an outcome interaction among sex, time, and commonly used prognostic variables. The important sex difference observed at 2 and 5 years suggests that more intensive consolidation and/or maintenance therapy in some boys with B-precursor ALL should be investigated.
Similar articles
-
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.J Clin Oncol. 1992 Apr;10(4):606-13. doi: 10.1200/JCO.1992.10.4.606. J Clin Oncol. 1992. PMID: 1548523
-
Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).Haematologica. 1998 Nov;83(11):967-73. Haematologica. 1998. PMID: 9864914
-
[Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1496-500. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22169311 Chinese.
-
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].Eur J Cancer. 2005 Jul;41(11):1570-83. doi: 10.1016/j.ejca.2004.11.004. Epub 2005 Jan 5. Eur J Cancer. 2005. PMID: 16026693 Review.
-
The role of immunophenotype in acute lymphoblastic leukemia of infant age.Leuk Lymphoma. 1994 Sep;15(1-2):51-60. doi: 10.3109/10428199409051677. Leuk Lymphoma. 1994. PMID: 7858502 Review.
Cited by
-
Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival.Rev Bras Hematol Hemoter. 2015 Jul-Aug;37(4):223-9. doi: 10.1016/j.bjhh.2015.03.009. Epub 2015 Apr 14. Rev Bras Hematol Hemoter. 2015. PMID: 26190424 Free PMC article.
-
Cancer survival and excess mortality estimates among adolescents and young adults in Western Australia, 1982-2004: a population-based study.PLoS One. 2013;8(2):e55630. doi: 10.1371/journal.pone.0055630. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405184 Free PMC article.
-
Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much.Cancers (Basel). 2021 Dec 22;14(1):32. doi: 10.3390/cancers14010032. Cancers (Basel). 2021. PMID: 35008193 Free PMC article. Review.
-
Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.Paediatr Drugs. 1999 Jul-Sep;1(3):197-209. doi: 10.2165/00128072-199901030-00004. Paediatr Drugs. 1999. PMID: 10937451 Review.
-
Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms.Exp Ther Med. 2012 Apr;3(4):665-672. doi: 10.3892/etm.2012.447. Epub 2012 Jan 9. Exp Ther Med. 2012. PMID: 22969948 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous